These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 30106956

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial.
    Amza A, Kadri B, Nassirou B, Stoller NE, Yu SN, Zhou Z, Chin S, West SK, Bailey RL, Mabey DC, Keenan JD, Porco TC, Lietman TM, Gaynor BD, PRET Partnership.
    PLoS Negl Trop Dis; 2012; 6(4):e1586. PubMed ID: 22545165
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.
    Harding-Esch EM, Sillah A, Edwards T, Burr SE, Hart JD, Joof H, Laye M, Makalo P, Manjang A, Molina S, Sarr-Sissoho I, Quinn TC, Lietman T, Holland MJ, Mabey D, West SK, Bailey R, Partnership for Rapid Elimination of Trachoma (PRET) study group.
    PLoS Negl Trop Dis; 2013; 7(6):e2115. PubMed ID: 23785525
    [Abstract] [Full Text] [Related]

  • 29. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania.
    West SK, Munoz B, Mkocha H, Gaydos CA, Quinn TC.
    J Infect Dis; 2011 Jul 15; 204(2):268-73. PubMed ID: 21673038
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Antibiotics for trachoma.
    Evans JR, Solomon AW.
    Cochrane Database Syst Rev; 2011 Mar 16; (3):CD001860. PubMed ID: 21412875
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study.
    West SK, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon AW, Foster A, Bailey RL, Mabey DC.
    Lancet; 2005 Oct 08; 366(9493):1296-300. PubMed ID: 16214600
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children.
    Pickering H, Ramadhani AM, Massae P, Mafuru E, Malisa A, Mbuya K, Makupa W, Mtuy T, Derrick T, Houghton J, Bailey RL, Mabey DCW, Burton MJ, Holland MJ.
    Front Public Health; 2022 Oct 08; 10():1015714. PubMed ID: 36324475
    [Abstract] [Full Text] [Related]

  • 36. Childhood Mortality After Mass Distribution of Azithromycin: A Secondary Analysis of the PRET Cluster-randomized Trial in Niger.
    O'Brien KS, Cotter SY, Amza A, Kadri B, Nassirou B, Stoller NE, Zhou Z, West SK, Bailey RL, Keenan JD, Porco TC, Lietman TM.
    Pediatr Infect Dis J; 2018 Nov 08; 37(11):1082-1086. PubMed ID: 29561511
    [Abstract] [Full Text] [Related]

  • 37. Trachoma prevalence remains below threshold in five districts after stopping mass drug administration: results of five surveillance surveys within a hyperendemic setting in Amhara, Ethiopia.
    Nash SD, Stewart AEP, Astale T, Sata E, Zerihun M, Gessese D, Melak B, Ayenew G, Ayele Z, Bayissasse B, Chanyalew M, Tadesse Z, Callahan EK.
    Trans R Soc Trop Med Hyg; 2018 Dec 01; 112(12):538-545. PubMed ID: 30265355
    [Abstract] [Full Text] [Related]

  • 38. Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma.
    Keenan JD, Ayele B, Gebre T, Moncada J, Stoller NE, Zhou Z, Porco TC, McCulloch CE, Gaynor BD, Emerson PM, Schachter J, Lietman TM.
    Clin Infect Dis; 2012 Jan 15; 54(2):253-6. PubMed ID: 22095569
    [Abstract] [Full Text] [Related]

  • 39. Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions.
    Keenan JD, See CW, Moncada J, Ayele B, Gebre T, Stoller NE, McCulloch CE, Porco TC, Gaynor BD, Emerson PM, Schachter J, Lietman TM.
    Invest Ophthalmol Vis Sci; 2012 Jan 25; 53(1):235-40. PubMed ID: 22159017
    [Abstract] [Full Text] [Related]

  • 40. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.
    Harding-Esch EM, Holland MJ, Schémann JF, Sillah A, Sarr B, Christerson L, Pickering H, Molina-Gonzalez S, Sarr I, Andreasen AA, Jeffries D, Grundy C, Mabey DCW, Herrmann B, Bailey RL.
    Parasit Vectors; 2019 Oct 22; 12(1):497. PubMed ID: 31640755
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.